Access Pharmaceuticals, Inc.
Drug delivery-focused company receives notice of AMEX delisting
Published in Pharma Investments, Ventures and Law Weekly, March 5th, 2006
Access Pharmaceuticals, Inc., (AKC) announced its receipt of an American Stock Exchange (AMEX) Listing Qualifications Department determination denying the company's appeal of an AMEX Staff Determination on December 12, 2005 which found that the company failed to comply with AMEX's continued listing standards due to losses from continuing operations and/or net losses in two of its most recent fiscal years with shareholders' equity of less than $2 million.
This is set forth in Section 1003(a)(i) of the AMEX "Company Guide"; due to losses from continuing operations and/or net losses in 3 of its most recent fiscal years with shareholders' equity of less than $4 million, as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Abiomed, Inc.
Cardiac device maker reports 10% increase in revenue - Aceto Corp.
Chemically derived drug distributor posts decline in revenue - Adams Respiratory Therapeutics, Inc.
Drug developer focused on respiratory diseases reports 75% increase in sales - Advanced Life Sciences Holdings, Inc.
SBIR grant to be used for study of drug for stroke patients - Aksys, Ltd.
Dialysis systems maker responds to Nasdaq notification - Akzo Nobel
Pharmaceutical division to be separated from parent company - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
